Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR8008 vs Fluconazole in Acute Vulvovaginal Candidiasis
NCT04956419Phase 3Unknown
- Sponsor
- Hengrui
- Start
- Apr 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oteseconazole in vulvovaginal candidiasis (VVC), sponsored by Hengrui. Status: unknown.
02
Drugs
oteseconazole
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT04956419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04956419.